Biblio

Tison A, Quere G, Misery L, Lesimple T, Marcq M, Martinez S, Brunet-Possenti F, Mansard S, Beneton N, Lambert M et al..  2017.  Safety of Immune Checkpoint Inhibitors for the Treatment of Melanoma, Bronchopulmonary and Urologic Neoplasms in Patients with Preexisting Autoimmune Disease. ARTHRITIS & RHEUMATOLOGY. 69

Tison A., Quere G., Misery L., Geier M., Lesimple T., Marcq M., Martinez S., Brunet-Possenti F., Mansard S., Beneton N. et al..  2017.  Safety of Immune Checkpoint Inhibitors in Patients with Preexisting Autoimmune Disease. JOURNAL OF THORACIC ONCOLOGY. 12:S2424.

Bardou M, Fortinsky KJ.  2015.  Safety of medication options for treating pediatric esophagitis. EXPERT OPINION ON DRUG SAFETY. 14:1087-1096.

Lombardi J, Boulin M, Devaux M, Cransac A, Pistre P, Pernot C, Payssot A, Lafon I, Caillot D, Gueneau P.  2021.  Safety of ninety-minute daratumumab infusion. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 27:1078155220951231.

de Sousa DAguiar, Canhao P, Crassard I, Coutinho J, Arauz A, Conforto A, Bejot Y, Giroud M, Ferro JM, Investigators ISCVT-2-PREGNANCY.  2017.  Safety of Pregnancy After Cerebral Venous Thrombosis Results of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis)-2 PREGNANCY Study. STROKE. 48:3130+.

D. de Sousa A, Canhao P., Crassard I., Coutinho J., Arauz A., Conforto A., Giroud M., Ferro J.MMC.  2015.  Safety of pregnancy following cerebral venous thrombosis (ISCVT2-PREGNANCY). EUROPEAN JOURNAL OF NEUROLOGY. 22:898.

D. de Sousa A, Canhao P., Crassard I., Coutinho J., Arauz A., Conforto A., Giroud M., Ferro J.MMC.  2015.  Safety of pregnancy following cerebral venous thrombosis (ISCVT2-PREGNANCY). EUROPEAN JOURNAL OF NEUROLOGY. 22:898.

Gherli R, Mariscalco G, Dalen M, Onorati F, Perrotti A, Chocron S, Verhoye JPhilippe, Gulbins H, Reichart D, Svenarud P et al..  2016.  Safety of Preoperative Use of Ticagrelor With or Without Aspirin Compared With Aspirin Alone in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Grafting. JAMA CARDIOLOGY. 1:921-928.

Anty R., Favre G., Coilly A., Rossignol E., Houssel-Debry P., Duvoux C., De Ledinghen V, Di Martino V, Leroy V, Radenne S. et al..  2018.  Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 47:1682-1689.

Toussirot E., Bernard C., Bossert M..  2019.  Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 37:344+.

Toussirot E., Bernard C., Bossert M..  2019.  Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 37:344+.

Toussirot E., Bereau M., Bernard C., Bossert M..  2019.  Safety of the use of anti-IL17A treatment in a patient with TNF inhibitor-induced sarcoidosis. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 33:61.

Toussirot E., Bereau M., Bernard C., Bossert M..  2019.  Safety of the use of anti-IL17A treatment in a patient with TNF inhibitor-induced sarcoidosis. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 33:61.

Verhoeven F., Weil-Verhoeven D., Thevenot T., Prati C., Di Martino V., Wendling D..  2018.  SAFETY OF TNF BLOCKERS IN CASE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND CIRRHOSISA SYSTEMATIC REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 77:1381-1382.

Verhoeyen F, Weil-Verhoeyen D, Prati C, Di Martino V, Theyenot T, Wendling D.  2020.  Safety of TNF inhibitors in rheumatic disease in case of NAFLD and cirrhosis. SEMINARS IN ARTHRITIS AND RHEUMATISM. 50:544-548.

Wils P, Seksik P, Stefanescu C, Nancey S, Allez M, de Chambrun GPineton, Altwegg R, Gilletta C, Vuitton L, Viennot S et al..  2021.  Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 53:460-470.

Cottin J, Gouraud A, Jean-Pastor M-J, Disson-Dautriche A, Boulay C, Geniaux H, Auffret M, Bernard N, Descotes J, Vial T.  2016.  Safety profile of etifoxine: A French pharmacovigilance survey. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 30:147-152.

Sabatier R, Dieras V, Pivot X, Brain E, Roche H, Extra J-M, Monneur A, Provansal M, Tarpin C, Bertucci F et al..  2018.  Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer. CANCER RESEARCH AND TREATMENT. 50:1226-1237.

Chen A, Ding S, Kong L, Xu J, He F, Ru C, Lin X'ai.  2021.  Safflower injection inhibits pulmonary arterial remodeling in a monocrotaline-induced pulmonary arterial hypertension rat model. ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES. 76:27-34.

Midaoui AEl, Ghzaiel I, Vervandier-Fasseur D, Ksila M, Zarrouk A, Nury T, Khallouki F, Hessni AEl, Ibrahimi SOuazzani, Latruffe N et al..  2022.  Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases. NUTRIENTS. 14:597.

Russo D.  2018.  Saint Francis, objects and signs The invention of a modern image of holiness in religious art of the 13th and 14th centuries. REVUE DE L ART. :61-66.

Russo D.  2018.  Saint Francis, objects and signs The invention of a modern image of holiness in religious art of the 13th and 14th centuries. REVUE DE L ART. :61-66.

Dard-Morel G.  2019.  THE SAINT MARTIN CHURCH OF PURGEROT A BUILDING OF THE EARLY CISTERCIAN GOTHIC ART IN THE COUNTY OF BURGUNDY. BULLETIN MONUMENTAL. 177:19+.

Vergnolle E.  2016.  Saint-Benigne de Dijon. Fifty years of research on the abbey church in the year 1000. BULLETIN MONUMENTAL. 174:131+.

Vergnolle E.  2020.  Saint-Martial de Limoges, the abbey church of the Saviour. The Romanesque chevet according to textual and graphic documentation. BULLETIN MONUMENTAL. 178:7+.